MYRIAD GENETICS INC
S-3/A, EX-23.1, 2000-10-26
COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Previous: MYRIAD GENETICS INC, S-3/A, 2000-10-26
Next: COPART INC, 10-K405, 2000-10-26



<PAGE>

                                                                    Exhibit 23.1


                        Consent of Independent Auditors


The Board of Directors
Myriad Genetics, Inc.

We consent to incorporation by reference in Amendment No. 1 to the registration
statement on Form S-3 of Myriad Genetics, Inc. of our report dated August 22,
2000, related to the consolidated balance sheets of Myriad Genetics, Inc. and
subsidiaries as of June 30, 2000 and 1999 and the related consolidated
statements of operations, stockholders' equity and comprehensive loss and cash
flows for each of the years in the three-year period ended June 30, 2000, which
report appears in the June 30, 2000 annual report on Form 10-K of Myriad
Genetics, Inc., and the reference to our firm under the heading "Experts" in the
registration statement.

                                     KPMG LLP

Salt Lake City, Utah
October 26, 2000



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission